National Comprehensive Cancer Network



About NCCN

Melanoma Panel - Disclosures as of 4/12/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Robert Andtbacka, MD

None

None

None

None

9/6/2013

Christopher J. Anker, MD

None

None

None

None

3/1/2013

Christopher K. Bichakjian, MD

None

None

None

None

8/1/2013

William E. Carson III, MD

None

None

None

None

4/6/2013

Daniel G. Coit, MD

MSLT-II

None

None

None

3/9/2013

Adil I. Daud, MD

Abbott Laboratories;
GlaxoSmithKline;
Merck & Co., Inc.;
Pfizer Inc.;
Roche Laboratories, Inc.;
Schering-Plough Corporation;
Wyeth Pharmaceuticals

Bristol-Myers Squibb Company;
Merck & Co., Inc.

None

None

12/12/2011

Dominick DiMaio, MD

None

None

None

None

3/3/2013

Martin D. Fleming, MD, FACS

None

None

None

None

4/4/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Valerie Guild

None

None

None

None

4/8/2013

Allan C. Halpern, MD

Quintiles

None

None

None

3/1/2013

Maria Ho, PhD

None

None

None

None

8/14/2013

F. Stephen Hodi, MD

Bristol-Myers Squibb Company;
Genentech, Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Schering-Plough Corporation

Bristol-Myers Squibb Company;
MedImmune Inc.;
Novartis Pharmaceuticals Corporation;
EMD Serono Merck

None

None

4/4/2013

Mark C. Kelley, MD, MMHC, FACS

None

None

None

None

10/7/2012

Nikhil I. Khushalani, MD

None

Prometheus

None

None

5/3/2013

Ragini R. Kudchadkar, MD

Bristol-Myers Squibb Company;
Genentech, Inc.;
GlaxoSmithKline

Genentech, Inc.

None

None

5/16/2012

Julie R. Lange, MD, ScM

None

None

None

None

3/24/2013

Mary C. Martini, MD

Electro-Optical Sciences Inc

dove- unilever

None

None

4/7/2013

Joan S. McClure, MS

None

None

None

None

8/13/2013

Nicole McMillian, MS

None

None

None

None

3/9/2014

Anthony J. Olszanski, MD

None

Bristol-Myers Squibb Company;
Genentech, Inc.

None

None

4/4/2013

Merrick I. Ross, MD

None

Genentech, Inc.;
Genomic Health, Inc.;
GlaxoSmithKline;
Merck & Co., Inc.

None

None

8/10/2012

April Salama, MD

None

None

None

None

5/3/2013

Susan M. Swetter, MD

None

None

None

None

2/28/2013

Kenneth K. Tanabe, MD

None

None

None

None

12/30/2013

John A. Thompson, MD

Bristol-Myers Squibb Company;
Genentech, Inc.;
GlaxoSmithKline;
ImClone Systems Incorporated;
Novartis Pharmaceuticals Corporation;
Altor Biosciences

Bristol-Myers Squibb Company;
Genentech, Inc.

None

None

9/3/2013

Vijay Trisal, MD

None

None

None

None

6/2/2011

Marshall M. Urist, MD

None

None

None

None

5/2/2013